[Principles, methods and criteria for assessing the effectiveness of potentially cardiotonic compounds at the preclinical research stage].
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002316:Cardiotonic Agents / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical / Q000379:methods; D006321:Heart / Q000187:drug effects; D006333:Heart Failure / Q000188:drug therapy; D006439:Hemodynamics / Q000187:drug effects; D066298:In Vitro Techniques; D007928:Lethal Dose 50; D009200:Myocardial Contraction / Q000187:drug effects; D011379:Prognosis; D012107:Research Design; D013329:Structure-Activity Relationship; D009626:Terminology as Topic
D002316:Cardiotonic Agents
Printsipy, metody i kriterii otsenki éffektivnosti potentsial'no kardiotonicheskikh soedineniĭ na étape doklinicheskogo izucheniia.